Search for: "VALUE DRUG COMPANY" Results 1 - 20 of 3,465
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Nov 2021, 9:03 pm by Alana Sheppard
This system awards a drug with a price consistent with the value it adds to society, rewarding novel drugs with high prices but preventing arbitrarily and inaccessibly high valuations that pharmaceutical companies currently assign. [read post]
7 Dec 2018, 7:39 am by Jordan Ross
Pharmaceutical companies are prohibited from any exchange of remuneration (anything of value) to induce or provide referrals for drugs payable by a federal program via the Anti-Kickback Statute. [read post]
26 Oct 2021, 4:15 am by Jack Lu
Biogen stock price increased 38.3% on the day, adding $16.5 billion to the company’s market value. [read post]
14 Oct 2022, 5:16 am by Chenny Zhang
The first link in the value chain is R&D, during which researchers seek to understand a disease, identify and validate a target drug, and develop compounds. [read post]
18 Mar 2010, 8:10 am by John J. Cord
Interesting developments in online social media and drug companies, in the past week. [read post]
5 Oct 2007, 10:29 am
FDA predicts that the program, aptly called GIVE the Generic Initiative for Value and Efficiency, would give a gift to generic companies by helping the FDA approve generic drugs more quickly. [read post]
9 Sep 2019, 11:48 am by Nick J. Welle and Jessica M. Simons
  To address this issue, some health plans have been designed to exclude the value of any drug manufacturer coupons from the member’s annual deductible and OOPM. [read post]
15 Nov 2015, 9:39 am by Law Offices of Jeffrey S. Glassman
These are companies earning hundreds of billions of dollars each year, and the last thing they want to see is revenue down and their stock value falling. [read post]
12 Jan 2017, 11:11 am by Neil Wilkof
Landa's criticisms derive from the fact that, as he describes-- "[t]he company has lost half of its value. [read post]
27 Oct 2009, 2:13 am
Then these same drug companies spend millions to market these drugs to physicians; ultimately the only class of people who can really open the gate to consuming of drug company products. [read post]
26 Aug 2015, 12:53 pm by Bloomberg
Bethesda-based Sucampo Pharmaceuticals Inc. agreed to acquire Japan’s R-Tech Ueno Ltd. in a deal valued at about $276 million (33 billion yen), buying a company controlled by Sucampo’s founders that manufactures all of its drugs. [read post]
26 Oct 2021, 4:15 am by Jack Lu
Biogen stock price increased 38.3% on the day, adding $16.5 billion to the company’s market value. [read post]
22 Jun 2016, 3:12 am by Law Offices of Jeffrey S. Glassman
A recent article from Cleveland.com takes a look at how drug companies may be manipulating potential patients by asking them to speak to their doctors about a particular drug. [read post]
19 Oct 2014, 4:10 pm by Steve Kalar
   A: When it is a list of potentially eligible inmates, for a drug resentencing reduction. [read post]
2 Jul 2010, 1:25 pm
The bill will now require action by the Senate.Presumption of Anticompetitive EffectsUnder the measure, patent settlements would be presumed to have anticompetitive effects and be unlawful where a potential generic competitor receives “anything of value” from a branded drug company in return for agreeing “to limit or forego research, development, manufacturing, marketing, or sales” of a competing drug. [read post]
23 Jul 2010, 11:24 am by Mark J. Caruso, attorney
Let's also assume that your medical bills are at about $8,000.00Given these limited facts, I would value the case at about $24,000 but most insurance companies would offer you $12,000--less than half the amount of my value. [read post]
15 Sep 2015, 8:40 am by Law Offices of Jeffrey S. Glassman
To make matters worse, drug companies spend millions of dollars making up new names for old, rare diseases to increase demand for their drugs. [read post]
12 Oct 2022, 9:05 pm by Trevor Kirby
Identified actions include testing value-based payment models that directly link drug costs to the clinical value provided to patients, advocating direct competition between brand-name and generic drugs, and enhancing transparency related to drug prices, rebates, and out-of-pocket expenses. [read post]